Category: Cardinal Health
Healthcare giant Cardinal Health posts declines in its major drug business during its 4th quarter, but cost-control measures and gains in its smaller medical supplies division help beat analysts' estimates.
Ohio healthcare giant Cardinal Health (NYSE:CAH) got no Wall Street love after posting estimate-beating earnings today.
Sunshine Heart taps ex-Boston Scientific cardiovascular R&D veteran Brian Brown as its new vice president for operations & technology.
Cardinal Health CFO Jeff Henderson plans to step down next year, as the company looks without and within for his replacement.
Cardinal Health (NYSE:CAH) said Jeff Henderson is planning to step down at the end of fiscal 2015 after a decade as its chief financial officer.
Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott may look to expand medical device business footprint; Device makers take big writedowns on renal denervation; Cardinal Health closes $320M AccessClosure buy; K2M prices IPO under range at $132M; Allergan board spurns Valeant's $47B offer.
Access Closure Inc.
, Boston Scientific
, Cardinal Health
, Pershing Capital Management
, St. Jude Medical
, Valeant Pharmaceuticals
, Abbott Laboratories
, Allergan Inc.
Cardinal Health says it closed its $320 million all-cash buyout of AccessClosure and its Mynx extravascular closure technology.
Cardinal Health (NYSE:CAH) said today that it closed its $320 million all-cash acquisition of AccessClosure and its Mynx extravascular closure technology.
The Mynx biodegradable sealant products are designed to close off the femoral artery and then dissolve within 30 days.
Cardinal Health hopes to give its interventional devices suite a boost with the $320 million acquisition of AccessClosure and its Mynx biodegradable vascular sealants.
Ohio-based Cardinal Health (NYSE:CAH) made a $320 million all-cash bid to acquire AccessClosure and its extravascular closure technology.
Patient Safety Technologies agrees to make additional disclosures to settle shareholder lawsuits filed over its impending $120 million buyout by Stryker Corp.